Recent

% | $
Quotes you view appear here for quick access.

Rubicon Minerals Corporation Message Board

discdegeneration 5 posts  |  Last Activity: Apr 2, 2015 12:29 PM Member since: Jun 2, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    I find it somewhat interesting......

    by jacknjill777 Apr 2, 2015 10:44 AM
    discdegeneration discdegeneration Apr 2, 2015 12:29 PM Flag

    Warren Buffet said the stock market is where the patient take money from the impatient. I hope that applies here

  • Reply to

    What happen? why down 8%

    by egelone003 Mar 13, 2015 6:27 PM
    discdegeneration discdegeneration Mar 24, 2015 4:51 PM Flag

    Why up 8% when S&P market down 12?

  • Reply to

    Not Good

    by miltongm0918 Mar 18, 2015 2:13 PM
    discdegeneration discdegeneration Mar 18, 2015 4:00 PM Flag

    Form 20F

  • Reply to

    Not Good

    by miltongm0918 Mar 18, 2015 2:13 PM
    discdegeneration discdegeneration Mar 18, 2015 3:56 PM Flag

    I think this might be what he is referring to:

    In this regard we became aware at the end of 2014 that an active pharmaceutical ingredient and drug product intermediate manufacturer, Hovione, has submitted an IND for Phase I and II clinical trials of a new topical product containing minocycline for the treatment of inflammatory skin disease including acne and rosacea. If ultimately approved and launched in the U.S., such a product would become a direct competitor of FMX101 and 103, if commercialized.

    Hovione currently manufactures and supplies Foamix with pharmaceutical-grade minocycline for use in FMX101 and other products. This increases the risk that we will not have sufficient quantities of minocycline for use in FMX101, FMX102 or FMX103 at an acceptable cost or at all, which could delay, prevent or impair our development or commercialization efforts.

    Furthermore, such potential competitors may enter the market before us, and their products may be designed to circumvent our granted patents and pending patent applications. They may also challenge, narrow or invalidate our granted patents or our patent applications, and such patents and patent applications may fail to provide adequate protection for our product candidates

  • Reply to

    Disgusted & Disappointed

    by biospeculator2014 Feb 13, 2015 8:53 AM
    discdegeneration discdegeneration Feb 13, 2015 10:48 AM Flag

    I've seen it happen over and over again. It's pretty much the way it is

RBY
1.06-0.04(-3.64%)May 1 4:04 PMEDT